Rhythm Pharmaceuticals (RYTM) Free Cash Flow Growth (5y) (2021 - 2026)
Rhythm Pharmaceuticals (RYTM) Free Cash Flow Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - |
| 10 | Rhythm Pharmaceuticals | 7.32 Bn | 6.98 Bn | 52.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.46% |
| Dec 31, 2025 | 2.25% |
| Sep 30, 2025 | -3.34% |
| Jun 30, 2025 | 9.66% |
| Mar 31, 2025 | -2.20% |
| Dec 31, 2024 | 7.35% |
| Sep 30, 2024 | 6.42% |
| Jun 30, 2024 | -0.12% |
| Mar 31, 2024 | -4.20% |
| Dec 31, 2023 | -6.57% |
| Sep 30, 2023 | -10.72% |
| Jun 30, 2023 | -26.15% |
| Mar 31, 2023 | -25.68% |
| Dec 31, 2022 | -29.96% |
| Sep 30, 2022 | -43.74% |
| Jun 30, 2022 | -44.63% |
| Mar 31, 2022 | -50.27% |
| Dec 31, 2021 | -46.54% |